Inovio Pharmaceuticals Inc (NAS:INO)
$ 11.11 -0.89 (-7.42%) Market Cap: 287.87 Mil Enterprise Value: 218.74 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 48/100

Q1 2023 Inovio Pharmaceuticals Inc Earnings Call Transcript

May 10, 2023 / 08:30PM GMT
Release Date Price: $9.72 (-3.33%)
Operator

Good day, and welcome to the Inovio First Quarter 2023 Financial Results Conference Call. (Operator Instructions)

I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.

Thomas Hong

Good afternoon, and thank you for joining the Inovio 2023 first quarter conference call. Joining me on today's call are Dr. Jackie Shea, President and CEO; Dr. Michael Sumner, Chief Medical Officer; and Mr. Peter Kies, Chief Financial Officer. We also have other members of Inovio's leadership here with us today, who will be part of our Q&A session.

Today's call will review our corporate and financial information for the quarter and year ended March 31, 2023, as well as provide a development progress update for our DNA medicines platform. Following prepared remarks, we will conduct a question-and-answer segment.

During the call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Inovio's DNA

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot